Published in Lancet on October 30, 1976
The frontiers of cardiomyopathy. Br Heart J (1982) 1.98
Pre-excitation due to accessory sinoventricular connexions associated with coronary sinus aneurysms. A report of two cases. Br Heart J (1985) 1.38
Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J (1980) 1.20
Role of calcium antagonists in cardiovascular therapy. Br Heart J (1981) 0.98
Nonobstructive and obstructive hypertrophic cardiomyopathies. West J Med (1979) 0.94
Syncope in hypertrophic cardiomyopathy. Br Heart J (1982) 0.78
Hypertrophic Cardiomyopathy. Curr Treat Options Cardiovasc Med (1999) 0.76
Arrhythmia in hypertrophic cardiomyopathy. Br Med J (1980) 0.75
Haemodynamic effects of nifedipine and propranolol in patients with hypertrophic obstructive cardiomyopathy. Br Heart J (1982) 0.75
Unusual sudden death. Trans Am Clin Climatol Assoc (1985) 0.75
Radionuclide assessment of left ventricular function in hypertrophic cardiomyopathy. Postgrad Med J (1986) 0.75
Postextrasystolic changes in systolic time intervals in the assessment of hypertrophic cardiomyopathy. Br Heart J (1982) 0.75
Career prospects in cardiology in England and Wales. Survey and 15 health regions. Br Heart J (1981) 8.82
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
Torsade De Pointes, an atypical ventricular tachycardia. Br Heart J (1976) 4.22
The cardiomyopathies. Br Heart J (1972) 3.14
Immediate effects of intravenous verapamil in cardiac arrhythmias. Br Med J (1972) 3.05
Side effects of long-term amiodarone therapy. Circulation (1983) 3.03
Acute subvalvar mitral incompetence. Lancet (1966) 2.65
Community study of the causes of "natural" sudden death. BMJ (1988) 2.44
Therapeutic defibrination in the treatment of thrombotic disease. Lancet (1968) 2.40
Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J (1985) 2.22
Left ventricular filling in hypertrophic cardiomyopathy. An angiographic study. Br Heart J (1977) 2.18
Verapamil in the treatment of paroxysmal supraventricular tachycardia. Postgrad Med J (1974) 2.08
Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet (1973) 2.04
Acute rheumatic fever and carditis in older adults. Lancet (1966) 2.01
The frontiers of cardiomyopathy. Br Heart J (1982) 1.98
Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med (1983) 1.96
Endomyocardial fibrosis in Europeans resident in tropical Africa. Lancet (1967) 1.93
Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis. Br Heart J (1981) 1.91
Prospects and predictions for the cardiomyopathies. Circulation (1974) 1.87
Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J (1979) 1.86
Effects of surgical closure of ventricular septal defects upon pulmonary vascular disease. Br Heart J (1969) 1.86
Life-threatening arrhythmias and intravenous cimetidine. Br Med J (1979) 1.81
The spectrum of cardiac tumors. Am J Cardiol (1968) 1.72
M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction. Am J Cardiol (1980) 1.72
Paracetamol and the kidney. Br Med J (1967) 1.68
Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. Br Heart J (1980) 1.64
Cardiovascular features of 11 patients with eosinophilic endomyocardial disease. Q J Med (1983) 1.62
Left ventricular angiography on exercise. A new method of assessing left ventricular function in ischaemic heart disease. Br Heart J (1976) 1.60
Cine angiography of left ventricular aneurysms. Clin Radiol (1972) 1.53
Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy. Br Med J (1966) 1.53
Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol. Br Heart J (1983) 1.52
Congestive and hypertrophic cardiomyopathies. A decade of study. Lancet (1970) 1.51
Left ventricular relaxation and filling in hypertrophic cardiomyopathy. An echocardiographic study. Br Heart J (1978) 1.50
The colorimetric determination of iron in biological material with reference to its measurement during chelation therapy. Clin Chem (1966) 1.49
Beneficial effect of salbutamol on cardiac function in severe congestive cardiomyopathy. Effect on systolic and diastolic function of the left ventricle. Circulation (1978) 1.48
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. Br Heart J (1981) 1.46
Ventricular tachycardia of left bundle branch block configuration in patients with isolated right ventricular dilatation. Clinical and electrophysiological features. Br Heart J (1984) 1.42
Side effects and possible contraindications of amiodarone use. Am Heart J (1983) 1.40
Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy. Am J Cardiol (1980) 1.30
Regional left ventricular wall movement in hypertrophic cardiomyopathy. Br Heart J (1978) 1.29
Punishment of doctors must fit their crime. BMJ (1998) 1.27
Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. Am J Cardiol (1984) 1.26
The relationship between posture, blood pressure and electrophysiological properties in patients with paroxysmal supraventricular tachycardia. Arch Mal Coeur Vaiss (1978) 1.25
Echocardiographic features of eosinophilic endomyocardial disease. Br Heart J (1982) 1.24
Transplantation of the heart. Am Heart J (1969) 1.23
Studies in acute iron poisoning. I. Desferrioxamine in the treatment of acute iron poisoning: clinical observations, experimental studies, and theoretical considerations. Pediatrics (1965) 1.23
Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy. Br Heart J (1970) 1.23
Hydralazine in the management of left ventricular failure. Am J Cardiol (1979) 1.21
Thyroid function in coronary-artery disease. Lancet (1971) 1.20
Treatment of the cardiomyopathies. Am J Cardiol (1973) 1.20
Electrocardiography then and now: where next? Br Heart J (1987) 1.20
Urgent aortic-valve replacement for acute aortic regurgitation due to infective endocarditis. Lancet (1971) 1.20
Sudden death in hypertrophic cardiomyopathy: associated accessory atrioventricular pathways. Br Heart J (1980) 1.20
Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy. Br Heart J (1973) 1.17
Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population. Br Med J (1974) 1.16
Concealed bypasses of the atrioventricular mode in patients with paroxysmal supraventricular tachycardia revealed by intracardiac electrical stimulation and verapamil. Am J Cardiol (1974) 1.14
Intermittent left bundle-branch block without obvious heart-disease. Lancet (1970) 1.14
Electrophysiological manifestations of non-penetrating cardiac trauma. Br Heart J (1980) 1.12
Successful surgical treatment of two patients with eosinophilic endomyocardial disease. Br Heart J (1981) 1.12
Double outlet right ventricle with pulmonary stenosis. Br Heart J (1967) 1.10
Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome. Br Heart J (1974) 1.10
Targeting cell cycle and hormone receptor pathways in cancer. Oncogene (2013) 1.10
Editorial: Standards for electrocardiographs. Br Heart J (1974) 1.08
Nifedipine and propranolol: a beneficial drug interaction. Am J Med (1981) 1.08
Direct measurement of serum iron and binding capacity. Clin Chem (1966) 1.08
Q waves and coronary angiography in cardiomyopathy. Br Heart J (1970) 1.08
Diseases of Jews. Postgrad Med J (1970) 1.08
Left ventricular volume and hypertrophy in outflow obstruction. Cardiovasc Res (1968) 1.08
A fresh look at cardiac arrhythmias Pathogenesis and presentation. Lancet (1974) 1.07
Spectrophotometry of proline in plasma and urine. Clin Chem (1972) 1.07
Is there autonomic impairment in congestive (dilated) cardiomyopathy? Lancet (1981) 1.06
The natural history of left ventricular hypertrophy in hypertrophic cardiomyopathy: an electrocardiographic study. Circulation (1982) 1.06
Echocardiographic features of tropical endomyocardial disease in South India. Br Heart J (1983) 1.04
Amiodarone: the experience of the past decade. Br Med J (Clin Res Ed) (1983) 1.04
Electrocardiographic diagnosis. Lancet (1974) 1.04
Termination of focal atrial tachycardia by adenosine triphosphate. Br Heart J (1987) 1.03
"Torsade de pointes" initiated by electrical ventricular stimulation. J Electrocardiol (1976) 1.03
The challenge and the reproach of infective endocarditis. Br Heart J (1985) 1.02
Hypertrophic cardiomyopathy: a disease in search of its own identity. Am J Cardiol (1980) 1.02
Atherosclerosis: inhibition of regression as therapeutic possibilities. Br Heart J (1991) 1.01
Hypertrophy and obstruction of outflow tract of left ventricle. Br Heart J (1970) 1.01
The natural history of hypertrophic cardiomyopathy. Curr Probl Cardiol (1981) 1.00
The effect of beta-adrenergic blocking agents on serum lipids. Atherosclerosis (1972) 1.00
ABC of sports medicine. Sudden death in sport. BMJ (1994) 0.99
Retrograde invasion of the bundle branches producing aberration of the QRS complex during supraventricular tachycardia studied by programmed electrical stimulation. Circulation (1974) 0.99
Q waves and coronary arteriography in cardiomyopathy. Br Heart J (1972) 0.99
Blood pressure and heart rate in patients with ischaemic heart disease receiving nifedipine and propranolol. Br Med J (Clin Res Ed) (1982) 0.99
Long-term follow-up of atrial myxoma. Br Heart J (1972) 0.97
Randomised crossover trial of rate responsive Activitrax and conventional fixed rate ventricular pacing. Br Heart J (1987) 0.97
Wolff-Parkinson-White syndrome: long follow-up and an Anglo-American historical note. J Am Coll Cardiol (1983) 0.97
Delayed closure of the pulmonary valve in obliterative pulmonary hypertension. Lancet (1965) 0.96
The problem of lone atrial fibrillation. S Afr Med J (1967) 0.96
Electrocardiography: standards, techniques, and training. Lancet (1971) 0.96
An appreciation of hypertrophic cardiomyopathy. Am J Med (1980) 0.95
Mechanisms in cardiomyopathies. J Mol Cell Cardiol (1985) 0.94